Mayo Clinic has designed a new system to speed critical care to acute heart attack patients that dramatically reduces the time that elapses before patients undergo a life-saving procedure — by as much as 45 percent in some cases.
High-risk surgical patients in community hospital settings can safely benefit from the use of new embolus-removing and stent-inserting systems, according to a study presented today at the American College of Cardiology?s Innovation in Intervention: i2 Summit in New Orleans, La.
In patients undergoing cardiac catheterization, contrast dye injection can sometimes cause contrast-induced nephropathy (CIN), otherwise known as acute renal failure.
Parents might one day give their children a weekly treatment with a nasal spray of virus enzymes to prevent them from getting a severe middle ear infection, based on results of a study done in mice by investigators from St. Jude Children’s Research Hospital and The Rockefeller University, in New York.
A study published today in the Journal of Antimicrobial Chemotherapy provides the best available evidence that cases of Clostridium difficile infection (CDI) — one of the most common and increasing types of hospital-acquired infection — can be reduced in hospital wards if doctors prescribe narrow-spectrum antibiotics rather than broad-spectrum agents.
Forty-four percent of surgeons do not refer the majority of their breast cancer patients to a plastic surgeon prior to the initial surgery when the woman is choosing her treatment course, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
Genetics and family history play a large role in a person?s risk for heart disease, but factors in diet, lifestyle and the environment are also thought to influence susceptibility to the disease.
Heart problems in children are quite different from those in adults, and four studies presented today at the American College of Cardiology?s 56th Annual Scientific Session look at how pediatric cardiologists take different approaches to better understand and manage cardiovascular disease in this population, including insights into fundamental cardiac mechanisms and testing of new procedures.
The use of medicines to fight cardiovascular disease has been a primary focus of research in this area for the past several decades, as combinations of interventions and medicinal therapy have gradually begun to increase long-term survival rates.
Responding to the Health Select Committee?s report, ?Boom and Bust in the NHS?, Dr Sam Everington, Deputy Chairman of the BMA, said: